Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2014

Open Access 01-12-2014 | Case report

Acetaminophen-induced anion gap metabolic acidosis secondary to 5-oxoproline: a case report

Authors: Tarig Mohammed Abkur, Waleed Mohammed, Mohamed Ali, Liam Casserly

Published in: Journal of Medical Case Reports | Issue 1/2014

Login to get access

Abstract

Introduction

5-oxoproline (pyroglutamic acid), an organic acid intermediate of the gamma-glutamyl cycle, is a rare cause of high anion gap metabolic acidosis. Acetaminophen and several other drugs have been implicated in the development of transient 5-oxoprolinemia in adults. We believe that reporting all cases of 5-oxoprolinemia will contribute to a better understanding of this disease. Here, we report the case of a patient who developed transient 5-oxoprolinemia following therapeutic acetaminophen use.

Case presentation

A 75-year-old Caucasian woman was initially admitted for treatment of an infected hip prosthesis and subsequently developed transient high anion gap metabolic acidosis. Our patient received 40g of acetaminophen over a 10-day period. After the more common causes of high anion gap metabolic acidosis were excluded, a urinary organic acid screen revealed a markedly increased level of 5-oxoproline. The acidosis resolved completely after discontinuation of the acetaminophen.

Conclusion

5-oxoproline acidosis is an uncommon cause of high anion gap metabolic acidosis; however, it is likely that it is under-diagnosed as awareness of the condition remains low and testing can only be performed at specialized laboratories. The diagnosis should be suspected in cases of anion gap metabolic acidosis, particularly in patients with recent acetaminophen use in combination with sepsis, malnutrition, liver disease, pregnancy or renal failure. This case has particular interest in medicine, especially for the specialties of nephrology and orthopedics. We hope that it will add more information to the literature about this rare condition.
Appendix
Available only for authorised users
Literature
1.
go back to reference Pitt JJ, Hauser S: Transient 5-oxoprolinuria and high anion gap metabolic acidosis: clinical and biochemical findings in eleven subjects. Clin Chem. 1998, 44 (7): 1497-1503.PubMed Pitt JJ, Hauser S: Transient 5-oxoprolinuria and high anion gap metabolic acidosis: clinical and biochemical findings in eleven subjects. Clin Chem. 1998, 44 (7): 1497-1503.PubMed
2.
go back to reference Kortmann W, Van Agtmael MA, van Diessen J, Kanen BL, Jakobs C, Nanayakkara PW: 5-oxoproline as a cause of high anion gap metabolic acidosis: an uncommon cause with common risk factors. Neth J Med. 2008, 66 (8): 354-357.PubMed Kortmann W, Van Agtmael MA, van Diessen J, Kanen BL, Jakobs C, Nanayakkara PW: 5-oxoproline as a cause of high anion gap metabolic acidosis: an uncommon cause with common risk factors. Neth J Med. 2008, 66 (8): 354-357.PubMed
3.
go back to reference Njalsson R: Glutathione synthetase deficiency. Cell Mol Life Sci. 2005, 62 (17): 1938-1945. 10.1007/s00018-005-5163-7.CrossRefPubMed Njalsson R: Glutathione synthetase deficiency. Cell Mol Life Sci. 2005, 62 (17): 1938-1945. 10.1007/s00018-005-5163-7.CrossRefPubMed
4.
go back to reference Meister A: The γ-glutamyl cycle: diseases associated with specific enzyme deficiencies. Ann Intern Med. 1974, 81 (2): 247-253. 10.7326/0003-4819-81-2-247.CrossRefPubMed Meister A: The γ-glutamyl cycle: diseases associated with specific enzyme deficiencies. Ann Intern Med. 1974, 81 (2): 247-253. 10.7326/0003-4819-81-2-247.CrossRefPubMed
5.
go back to reference Liss DB, Paden MS, Schwarz ES, Mullins ME: What is the clinical significance of 5- oxoproline (pyroglutamic acid) in high anion gap metabolic acidosis following paracetamol (acetaminophen) exposure?. Clin Toxicol. 2013, 51: 817-827. 10.3109/15563650.2013.844822.CrossRef Liss DB, Paden MS, Schwarz ES, Mullins ME: What is the clinical significance of 5- oxoproline (pyroglutamic acid) in high anion gap metabolic acidosis following paracetamol (acetaminophen) exposure?. Clin Toxicol. 2013, 51: 817-827. 10.3109/15563650.2013.844822.CrossRef
6.
go back to reference Brooker G, Jeffery J, Nataraj T, Sair M, Ayling R: High anion gap metabolic acidosis secondary to pyroglutamic aciduria (5-oxoprolinuria): association with prescription drugs and malnutrition. Ann Clin Biochem. 2007, 44 (4): 406-409. 10.1258/000456307780945769.CrossRefPubMed Brooker G, Jeffery J, Nataraj T, Sair M, Ayling R: High anion gap metabolic acidosis secondary to pyroglutamic aciduria (5-oxoprolinuria): association with prescription drugs and malnutrition. Ann Clin Biochem. 2007, 44 (4): 406-409. 10.1258/000456307780945769.CrossRefPubMed
7.
go back to reference Peter JV, Rogers N, Murty S, Gerace R, Mackay R, Peake SL: An unusual cause of severe metabolic acidosis. Med J Aust. 2006, 185 (4): 223-225.PubMed Peter JV, Rogers N, Murty S, Gerace R, Mackay R, Peake SL: An unusual cause of severe metabolic acidosis. Med J Aust. 2006, 185 (4): 223-225.PubMed
8.
go back to reference Dempsey GA, Lyall HJ, Corke CF, Scheinkestel CD: Pyroglutamic acidemia: a cause of high anion gap metabolic acidosis. Crit Care Med. 2000, 28 (6): 1803-1807. 10.1097/00003246-200006000-00018.CrossRefPubMed Dempsey GA, Lyall HJ, Corke CF, Scheinkestel CD: Pyroglutamic acidemia: a cause of high anion gap metabolic acidosis. Crit Care Med. 2000, 28 (6): 1803-1807. 10.1097/00003246-200006000-00018.CrossRefPubMed
9.
go back to reference Fenves AZ, Kirkpatrick HM, Patel VV, Sweetman L, Emmett M: Increased anion gap metabolic acidosis as a result of 5-oxoproline (pyroglutamic acid): a role for acetaminophen. Clin J Am Soc Nephrol. 2006, 1 (3): 441-447. 10.2215/CJN.01411005.CrossRefPubMed Fenves AZ, Kirkpatrick HM, Patel VV, Sweetman L, Emmett M: Increased anion gap metabolic acidosis as a result of 5-oxoproline (pyroglutamic acid): a role for acetaminophen. Clin J Am Soc Nephrol. 2006, 1 (3): 441-447. 10.2215/CJN.01411005.CrossRefPubMed
10.
go back to reference Tailor P, Raman T, Garaganta CL, Njalsson R, Carlsson K, Ristoff E, Carey HB: Recurrent high anion gap metabolic acidosis secondary to 5-oxoproline (pyroglutamic acid). Am J Kidney Dis. 2005, 46 (1): e4-e10. 10.1053/j.ajkd.2005.03.021.CrossRefPubMed Tailor P, Raman T, Garaganta CL, Njalsson R, Carlsson K, Ristoff E, Carey HB: Recurrent high anion gap metabolic acidosis secondary to 5-oxoproline (pyroglutamic acid). Am J Kidney Dis. 2005, 46 (1): e4-e10. 10.1053/j.ajkd.2005.03.021.CrossRefPubMed
Metadata
Title
Acetaminophen-induced anion gap metabolic acidosis secondary to 5-oxoproline: a case report
Authors
Tarig Mohammed Abkur
Waleed Mohammed
Mohamed Ali
Liam Casserly
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2014
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/1752-1947-8-409

Other articles of this Issue 1/2014

Journal of Medical Case Reports 1/2014 Go to the issue